Dr. Sivakumar (Siva) Gajjeraman earned his doctoral degree in Biological Science from Anna University, India, and later worked as a Sr. Research Associate at Brown University and Northwestern University as a senior researcher.
Siva is a strategic, results-oriented protein science and analytical method development leader with extensive industry experience as a Principal Scientist, advancing complex biologics across discovery, clinical, and commercial stages. His expertise spans Chemistry, Manfacturing, and Controls (CMC), validated analytical method development, process development, technology transfer, and regulatory support for Investigational New Drug (IND) and Biologics License Application (BLA) filings, as well as post marketing requirements. Siva has led cross-functional teams within Contract Development and Manufacturing Organizations (CDMO) and Contract Research Organizations (CRO) to enhance efficiency, ensure regulatory readiness, and optimize biologics development.
Siva joined VIDO in 2025 and now leads the Non‑Regulatory Product Development (NRPD) group, where he brings scientific depth, collaborative leadership, and a strong commitment to advancing VIDO’s vision and mission.
Siva is a strategic, results-oriented protein science and analytical method development leader with extensive industry experience as a Principal Scientist, advancing complex biologics across discovery, clinical, and commercial stages. His expertise spans Chemistry, Manfacturing, and Controls (CMC), validated analytical method development, process development, technology transfer, and regulatory support for Investigational New Drug (IND) and Biologics License Application (BLA) filings, as well as post marketing requirements. Siva has led cross-functional teams within Contract Development and Manufacturing Organizations (CDMO) and Contract Research Organizations (CRO) to enhance efficiency, ensure regulatory readiness, and optimize biologics development.
Siva joined VIDO in 2025 and now leads the Non‑Regulatory Product Development (NRPD) group, where he brings scientific depth, collaborative leadership, and a strong commitment to advancing VIDO’s vision and mission.
Responsibilities as NRPD lead
- Provide strategic scientific leadership to the NRPD group, integrating expertise in vaccine and antibody development, analytical sciences, expression platforms, data interpretation, regulatory expectations, and technical documentation to ensure high‑quality project outcomes aligned with VIDO’s priorities.
- Collaborate closely with the Director of Vaccine Development to identify and prioritize internal and external projects that align with the strengths and growth trajectory of the NRPD team.
- Support the Vaccine Development Centre (VDC) at VIDO—a CL3‑capable GMP pilot facility enabling the development and manufacture of both veterinary and human vaccines—by contributing scientific insights, analytical strategy, and cross-functional coordination.
Research Interest
- Subunit protein or nucleic acid-based antibody/vaccine development for various emerging and re-emerging infectious diseases.
- Process and analytical method development, and validation of methods for preclinical and clinical studies, as well as stability and release studies (GMP and non-GMP).